Concentra, Medical Centers

Concentra Expands with Nova Medical Acquisition
Concentra Group Holdings Parent, Inc. ( ($CON) ) has released its Q4 earnings. Here is a breakdown of the information Concentra Group Holdings
Concentra’s Strategic Acquisition of Nova Medical Centers Enhances Service Offerings and Financial Outlook, Leading to Buy Recommendation
Mizuho Securities analyst Ann Hynes has maintained their bullish stance on CON stock, giving a Buy rating yesterday.Invest with Confidence:
Concentra anticipates growth with Nova Medical acquisition
Concentra Group Holdings Parent, Inc. (NYSE: CON), a leader in occupational health services with a market capitalization of $2.84 billion, has announced preliminary financial results for the fourth quarter and full year of 2024 and has signed an agreement to acquire Nova Medical (TASE:PMCN) Centers.
Concentra Announces Preliminary 2024 Financial Results, Agreement To Acquire Nova Medical Centers, and 2025 Financial Guidance
Concentra Group Holdings Parent, Inc. ("Concentra," "the Company," "we," "us," or "our") (NYSE: CON), the nation’s largest provider of occupational health services, today released preliminary unaudited financial results for the fourth quarter and full year ended December 31,
Concentra Group Holdings Parent, Inc. Announces Equity Purchase Agreement with Nova Medical Centers
Concentra Group Holdings Parent, Inc. (NYSE: CON) recently disclosed a significant development through an 8-K filing with the Securities and Exchange Commission. On January 22, 2025, the company revealed that its subsidiary,
Positive Outlook for Concentra Group Holdings Parent, Inc. Driven by Strategic Acquisition and Strong Financial Performance
Wells Fargo analyst Stephen Baxter has maintained their bullish stance on CON stock, giving a Buy rating today.Invest with Confidence: Follow
Concentra Group Holdings Parent Inc (CON) Q4 2024 Earnings Call Highlights: Strong Revenue ...
Concentra reports a robust quarter with significant EBITDA growth and a promising outlook following the Nova Medical Centers acquisition.
Concentra price target raised to $25 from $24 at BofA
BofA raised the firm’s price target on Concentra (CON) to $25 from $24 and keeps a Buy rating on the shares after the company announced an ...